Clinical Trials Logo

Familial Hypertriglyceridemia clinical trials

View clinical trials related to Familial Hypertriglyceridemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT06104943 Active, not recruiting - Clinical trials for Familial Hypertriglyceridemia

Stockholm hyperTRIglyceridemia REGister (STRIREG) Study

STRIREG
Start date: January 1, 2000
Phase:
Study type: Observational [Patient Registry]

The STRIREG study is a retrospective longitudinal general population-based register study including all individuals who had had at least one plasma Tg measurement between 1st January 2000 and 31st December 2021 at Karolinska University Laboratory or Unilabs AB in Region Stockholm (population 2.41 million 2021). The exclusion criteria were a lack of a unique Swedish personal identification number (PIN). The index population consisted of 1,460,184 individuals between the age 0 and 107 years. The index population was extended to form the complete cohort (n=3,607,819) by associating the parents and the siblings (n=2,147,635) to the indexes by interlinkage of personal identification numbers via the Multi-Generation register (see below). The study baseline for the index population was defined as the date for participant's first Tg measurement.

NCT ID: NCT00465751 Completed - Metabolic Syndrome Clinical Trials

Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism

Start date: October 2004
Phase: Phase 0
Study type: Interventional

The purpose of this study is to determine whether chenodeoxycholic acid decreases de novo hepatic lipogenesis, hepatic fat content, hepatic triglyceride production and plasma triglyceride concentrations and improves hepatic glucose metabolism in patients with the metabolic syndrome, Familial Hypertriglyceridemia and Familial Combined Hyperlipidemia.